Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Marchetti

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Open Forum Infectious Diseases|March 16, 2022
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive SubjectsDebora Mondatore, Francesca Bai, Matteo Augello, et al.
Frontiers in Immunology|January 10, 2017
Stimulation of PBMC and Monocyte-Derived Macrophages <i>via</i> Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral TherapyEsther Merlini, Camilla Tincati, Mara Biasin, et al.
The Journal of Infection|March 13, 2023
Inflammation burden score in multidrug-resistant HIV-1 infectionTommaso Clemente, Roberta Caccia, Laura Galli, et al.
Brain Research|December 27, 2011
Disrupted pro- and antioxidative balance as a mechanism of neurotoxicity induced by perinatal exposure to leadIrena Baranowska-Bosiacka, Izabela Gutowska, Mariola Marchlewicz, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Incidence, Risk Factors and Impact on Clinical Outcomes of Bloodstream Infections in Patients Hospitalised with COVID-19: A Prospective Cohort StudyAndrea Cona, Alessandro Tavelli, Andrea Renzelli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 15, 2025
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulationRoberta Gagliardini, Andrea Giacomelli, Cristina Mussini, et al.
Expert Review of Anti-Infective Therapy|October 15, 2020
Enhancing care for people living with HIV: current and future monitoring approachesFranco Maggiolo, Alessandra Bandera, Stefano Bonora, et al.
Viruses|March 28, 2026
The Forgotten Test: Missed Opportunities for HIV Diagnosis and Survival Outcomes in Advanced HIV DiseaseArianna Narducci, Alessandra Vergori, Paola Borrelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2023
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Romina Salpini, et al.
Frontiers in Public Health|August 4, 2025
The impact of COVID-19 hospitalizations on nursing home admissions: a regional insight into long-term care and public healthAlessandra Bandera, Marta Colaneri, Alessia Antonella Galbussera, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Open Forum Infectious Diseases|March 16, 2022
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive SubjectsDebora Mondatore, Francesca Bai, Matteo Augello, et al.
Frontiers in Immunology|January 10, 2017
Stimulation of PBMC and Monocyte-Derived Macrophages <i>via</i> Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral TherapyEsther Merlini, Camilla Tincati, Mara Biasin, et al.
The Journal of Infection|March 13, 2023
Inflammation burden score in multidrug-resistant HIV-1 infectionTommaso Clemente, Roberta Caccia, Laura Galli, et al.
Brain Research|December 27, 2011
Disrupted pro- and antioxidative balance as a mechanism of neurotoxicity induced by perinatal exposure to leadIrena Baranowska-Bosiacka, Izabela Gutowska, Mariola Marchlewicz, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Incidence, Risk Factors and Impact on Clinical Outcomes of Bloodstream Infections in Patients Hospitalised with COVID-19: A Prospective Cohort StudyAndrea Cona, Alessandro Tavelli, Andrea Renzelli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 15, 2025
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulationRoberta Gagliardini, Andrea Giacomelli, Cristina Mussini, et al.
Expert Review of Anti-Infective Therapy|October 15, 2020
Enhancing care for people living with HIV: current and future monitoring approachesFranco Maggiolo, Alessandra Bandera, Stefano Bonora, et al.
Viruses|March 28, 2026
The Forgotten Test: Missed Opportunities for HIV Diagnosis and Survival Outcomes in Advanced HIV DiseaseArianna Narducci, Alessandra Vergori, Paola Borrelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2023
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Romina Salpini, et al.
Frontiers in Public Health|August 4, 2025
The impact of COVID-19 hospitalizations on nursing home admissions: a regional insight into long-term care and public healthAlessandra Bandera, Marta Colaneri, Alessia Antonella Galbussera, et al.
Pageof 5